Canada cites ethical concerns about data from foreign clinical studies; may issue guidance
This article was originally published in SRA
Health Canada, after learning that some companies have been submitting data from foreign clinical trials of doubtful integrity, is looking at whether further guidance is needed in this area and, if so, the type of guidance required1.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.